📌 Key Takeaways
- Topic: Fumed Silica CAS 112945-52-5: Identification, Properties and Safety Data
- Keywords: silica thickening agent
- Published: 2026-11-20 05:13:33
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is the Boiling Point of Silica (SiO₂)? Thermal Properties Explained
- How to Get a Free Silica Sample: What to Request and How to Test It
- Silica Filler for CCL: How It Improves Copper Clad Laminate Performance
- Song, Z. et al. Mesoporous silica-coated gold nanorods with a thermally responsive polymeric cap for near-infrared-activated drug delivery. J. Mater. Sci. 53, 7165-7179 (2018). Article CAS Google Scholar
- Thermal Conductive Filler: Silica vs Alumina vs Boron Nitride Compared
- Silica as a Reinforcing Agent: How It Improves Strength in Rubber and Polymers
- Hergt, R. et al. Enhancement of AC-losses of magnetic nanoparticles for heating applications. J. Magn. Magn. Mater. 280, 358-368 (2004). Article CAS Google Scholar
Silica as a Polishing Agent: How It Works and Where It Is Used
What is silica (SiO₂)?
silicon nitride The complexity and heterogeneity of the illness microenvironment brings about the problem of poor therapeutic efficiency of single therapies. 465, 466, 467, 468, 469 The current clinical research trend has steadily shifted to multimodal synergistic therapy, as we have noted above with many examples of multimodal synergistic therapy platform construction. In multimodal synergistic therapy, the interaction between different treatment modalities can substantially boost the shortcomings of single therapy, such as overcoming the lack of light penetration depth in PDT, lowering the toxic side effects of chemotherapy, etc., and producing stronger therapeutic outcome through superimposed impacts (namely "1 + 1 > 2"). 470, 471, 472 A prominent feature of multimodal synergistic therapies is the skill to effectively overcome multidrug resistance in diseases, and MSNs are uniquely advantageous in integrating these aforementioned treatment modalities. 369, 473, 474, 475 As an illustration, most of the multidrug resistance generated during chemotherapy of malignant tumors might stem from the overexpression of transmembrane ATP-binding cassette transporter and transmembrane Ca 2+ channels. 476, 477 To address this problem, researchers used mesoporous silica nanocapsules to encapsulate and deliver the cytotoxic drug DOX and T-type Ca 2+ channel siRNA. 478 On the one hand, MSNs can bypass the drug efflux pumps and enter cells directly through endocytosis, increasing the intracellular accumulation of drugs. On the other hand, siRNA can knock down the T-type Ca 2+ channel, leading to a decrease in cytosol Ca 2+ concentration in the cytosol, thus increasing the sensitivity of tumor cells to DOX. Accordingly, the as-designed MSNs-based therapeutic system attained effective chemotherapy-gene therapy to overcome the multidrug resistance in breast cancer. 478 Besides, drug-resistant bacterial infections are a current thorny public health issue. 479 In this regard, researchers have developed a photodynamic combined lysozyme antimicrobial therapy based on upconversion NPs/MSNs nanocomposites to combat the problem of drug-resistant bacterial infections in deep tissues. Briefly, upconversion NPs were sequentially encapsulated with hierarchical coating of dense silica and dendritic mesoporous silica, followed by loading photosensitizers and lysozyme, and finally modified with bacterial hyaluronidase-response valves on the MSNs surface to accomplish controllable release of lysozyme. The results demonstrated that this system promoted direct attack of ROS on cell membranes and cytoplasm through enzymatic cell wall disassembly, resulting in an excellent bactericidal rate toward methicillin-resistant Staphylococcus aureus (> 5 log10 viability reduction). 480
What is the difference between fumed silica and precipitated silica?
spherical silica for semiconductor packaging
What drives silica raw material prices?
antiblock agent for film Özalp, V. C. & Schäfer, T. Aptamer‐based switchable nanovalves for stimuli‐responsive drug delivery. Chem. Eur. J. 17, 9893-9896 (2011). Article PubMed Google Scholar
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.